(バイオ) 医薬品
変化の速い (バイオ) 医薬品の世界では、イノベーションがすべてです。知的財産を保護し、複雑な規制を順守し、適切な商取引契約を構築することは、投資を呼び込み、成長を可能にし、人生を変える治療法を市場に投入するために不可欠です。早期の戦略的な法的助言が、新薬を臨床試験や市場投入へと進めるベンチャー企業の成功と、機会を逃すかの分かれ目になります。
（バイオ）医薬品の新興企業およびスケールアップ企業への法的助言
私たちのチームは、知的財産、商業、規制、法律に関するアドバイスを組み合わせて、（バイオ）医薬品のイノベーターがビジネス価値と投資の可能性を最大化できるよう支援します。Stratiphyは、貴社のニーズに合わせた1つのまとまりのあるチームを用意し、お客様の旅のあらゆる段階で協力して考えます。
“Mark Lubbock is a high-level operator and tremendously impressive in negotiations.”
Services
We offer joined-up thinking across a comprehensive range of services:
IP strategy development and optimization
Proactive advice on patents and exclusivity
Leveraging IP and exit strategies
Commercial agreements
Competitor monitoring and litigation support
Legal Layer®: guiding you to the best outcome
Our team's fully-connected approach can help you to understand how your dealings with data and algorithms engage different aspects of IP and related areas of law. In this way, we serve as a “Legal Layer” to help you optimize outcomes for your business.
Paths through the neural network represent how certain features of data and algorithms can engage different legal considerations in the Legal Layer. Our Codiphy team considers these all together to optimise the outcomes for your business.
Click the buttons to show some examples of the many paths through the network.
Some AI models are trained on data scraped from publicly-available sources. This may have legal implications. For example, training an AI model using copyright works without obtaining a licence from the rightsholder could result in litigation and/or reputational damage. AI regulations will also play a role. For example, the EU AI Act will oblige General Purpose AI providers to publish summaries of training data and to respect opt-outs from data scraping. Otherwise, they could face penalties under the Act.
Proprietary algorithms may involve IP that can be protected, for example using trade secrets or patents. Competing factors need to be considered to optimise protection of that IP. For example, trade secret protection may extend an early-mover advantage, but will be lost if technical information is publicly leaked. Patents can provide protection even if the technical information is later published or if someone else develops the same idea independently, but filing a patent application for an idea that isn’t patentable may result in a loss of IP. An effective IP strategy will consider these factors and others to maximise the value in the IP.
Original code is protected by copyright, which may be licensed for others to use, for example under an open-source licence. Non-compliance with the obligations of an open-source licence may result in litigation and/or reputational damage. If you are considering releasing code under an open-source licence, it is important that this decision fits in with your business model and wider IP strategy, and that the licence you use supports these. Attempting to change licence terms after release can be difficult or impossible, and can cause reputational damage in the eyes of the open-source community.
AI models may be trained on, or may subsequently process, personal data that relates to an identified or identifiable natural person (including personal data that is publicly accessible). This may have legal implications if the training/processing is not compliant with data protection obligations. The party controlling the processing could face regulatory penalties including orders to stop the processing or using the AI model, litigation between the user and the controller, and/or reputational damage. Providers of AI systems should consider the principle of ‘privacy by design’, as well as ensuring contractual provisions are in place to mitigate the legal risk.
Our innovative combination of experienced specialists
当事務所のアドバイザーは、知的財産戦略と商法における豊富な経験を結集しています。私たちは、将来の収益源を守ることと、短期的にはお客様の投資と協業の可能性を最大限に引き出すことの両方において、知的財産が重要であることを理解しています。セクターに関する深い知識と実践的なアプローチにより、お客様が (バイオ) 製薬業界の複雑な状況に自信を持って乗り切れるよう支援します。
Discover our featured insights
Stay informed with the latest Consulting developments and the global IP landscape. Tune into our EIP Talks podcast, explore expert insights and browse our published articles and thought leadership, all designed to keep you ahead in the world of intellectual property.
Strategic licensing: Turning IP into commercial value
あなたにぴったりの商品を見つけましょう
私たちは、経営幹部から知財チームまで、クライアントと緊密に連携して、知的財産の可能性を最大限に引き出します。訴訟担当者、弁理士、商事知財の専門家から成る当社の統合チームは、特許を保護し、戦略的に活用することでビジネスの成長を促進します。
専門知識、業界、または場所で検索して、ビジネスに適したチームを見つけてください。